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T cells potentially encounter numerous endogenous peptides during selection in the thymus and 
in the periphery. We examined the impact of an endogenous peptide on in vivo T cell development, 
using a TCR transgenic mouse model based  on a hemoglobin-specific T  cell clone.  In these 
mice, the transgenic ~ chains paired with endogenous ot chains. This led to a serendipitous primary 
reactivity to Set69 peptide, an altered peptide ligand of the Hb  a (64-76)  epitope of the parent 
clone. Two Ser69-reactive T cell populations were identified. A smaller population of the Ser69- 
reactive T cells responded both to Set69 and Hb  a (64-76). A majority reacted only to Set69, and 
not to Hba(64-76);  in fact, Hba(64-76)  was a specific TCR antagonist for these Ser69-only- 
reactive T  cells. Thus, in this unique experimental system, Ser69 became an agonist, and Hb  a 
(64-76) was an antagonist. Endogenous presentation of  the antagonist ligand in the thymus selectively 
eliminated the high-avidity  cells, while sparing low-avidity cells in the Ser69-reactive T cell repertoire. 
These results highlight how specificity guides developing T cells through a network of ligands 
and indicate that the endogenous peptide pool has a profound effect on T cell development and 
repertoire. 
T 
he antigen specificity of the TCR is central to the trig- 
gering of T cell activation, clonal expansion, and effector 
functions. The TCR recognizes its antigen in the form of 
a peptide bound to an MHC molecule. Studies using vari- 
ants of antigenic peptides have shown that the TCR responds 
selectively to subtle changes in the ligand, underscoring its 
ability to behave as more than an all-or-none switch (1, 2). 
We have approached these issues of T  cell recognition by 
characterizing the T  cell response  to the B chain of murine 
hemoglobin, a  protein  with two  allelic  forms,  Hbb  s and 
Hbb  d.  The single antigenic determinant Hb  ~a~n~  (64-76) 
[hereafter referred to as Hbd(64-76)]  binds to I-E  k and is ex- 
pressed as a self-antigen in CBA/J (Hbb  a) mice, while it is 
recognized as foreign in CE/J (Hbb  s) mice.  Using variants 
of Hba(64-76),  termed altered  peptide ligands (APL),  we 
have demonstrated the induction of selective functions in T 
cell clones and hybridomas, including lymphokine produc- 
tion or cytolysis without proliferation (3, 4), anergy induc- 
tion (5, 6), and TCR antagonism (4). We report here a trans- 
genic mouse expressing  the/3  chain of the TCR from a 
Hbd(64-76)/I-Ek-specific  T cell clone, which has a fortuitous 
primary reactivity to an APL of Hbd(64-76).  We introduced 
the Hbd(64-76)-determinant  into the pool of endogenous 
peptide ligands by crossing these mice with Hbbd-expressing 
mouse strains and examined the effect of endogenous APL 
on thymic selection. 
Materials and Methods 
TCR-transgenic Mice.  The parent clone of the G2-Tg mice was 
the Hbd(64-76)/I-Ek-specific Th2  clone, 2.102, derived from a 
CE/J (Hbb S) mouse (7). Minigenes of the 2.102 TCR-c~ and -/8 
chains were constructed by insertion of  V-Jot and V-D-J/8 exon cas- 
settes into cr and/3 transgene shuttle vectors, respectively  (kindly 
provided by M. Davis (Stanford University, Palo Alto, CA) (8), 
then  coinjected into  (B6  x  SJL)F2 zygotes  at  DNX  Corp. 
(Princeton, NJ). Founder transgenic mice (G2-Tg) were obtained 
and backcrossed twice to CE/J mice to introduce the I-E  k restric- 
tion element and maintain homozygosity of the Hbb  s allele. PCR 
amplification of the a  transgene from tail digests identified trans- 
genic progeny (9). Mice used in the experiments described in this 
report were homozygous H-2  k/k by FACS or a PCR-based screen. 
Initial examination of thymocytes and splenocytes revealed no 
relative increase in CD4 § T cells in the transgenic progeny and 
a weak response to Hbd(64-76). The TCR-/8 chain transgene, a 
V/81-D/81-J/82.4 rearrangement, was functional and resulted  in sup- 
pression of endogenous/8  chain rearrangements  in >95% ofT cells, 
as determined by flow cytometry. In regard to the ~ chain (Vot2- 
Joe41) transgene, no increase in Vc~2  + T cells in G2-Tg mice was 
detected by an anti-Vot2 antibody (10). Another c~ transcript (Vot4- 
Jc~48) subsequently was isolated from the parent 2.102 clone that 
bore  strong homology to oe chains isolated from other Hbb  a- 
specific T cells, suggesting that the Vc~2 chain used to make the 
transgene was not involved in Hb recognition. 
Peptides.  The peptides used in these studies were synthesized, 
purified, and analyzed as previously  described (7). The peptide se- 
quences (in single-letter amino acid code) are as follows: Hba(64  - 
76), GKKVITAFNEGLK; Ser69, GKKVISAFNEGLK; Gln72, 
GKKVITAFQEGLK; and C/8, NGKEVHSGVSTKPQAYKE. 
T Cell Hybridomas.  Unprimed Tg LN cells were activated in 
vitro for 4 d with Ser69 peptide (15 /xM) and fused with the 
BW5147ot-/8- thymoma (11). Clonal hybridomas were tested for 
Ag specificity on CH27 APC as described (7). 
T cetIProtiferation  andAntagonism Assays.  Primary  LN and spleen 
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antagonist assays  of T cell hybridomas were performed as described 
(4). The antagonist assay for primary T cells was done similarly 
except that mitomycin C-treated, DCEK.Hi7 I-Ek-bearing L cells 
(5) prepulsed with 20 #M Ser69 were the stimulatory APC, and 
nylon wool-purified T cells (2  x  105) from Hbb  a/s TCR-trans- 
genic mice were used. 
Sequence Determination of TCR.  For sequence determination of 
endogenous TCR-a chains, total RNA was isolated from 1-4  x 
106 T hybridoma cells, and 2/zg RNA was reverse transcribed by 
use of random hexamers according to manufacturer's instructions 
for the RNA PCR kit (Perkin-Elmer Corp., Norwalk, CT). PCR 
was done in a thermocycler TempTronic (Thermolyne Corp., Du- 
buque, IA) on 1/20 of the reverse-transcription reaction using 15 
pmol Vc~ primer and 20 pmol Caa primer in a 50-gl reaction 
volume. Primers used were Val, Va4, Vc~5/7, Va6/12,  VaS, 
Va11,  Va15  (12); Caa, Va2,  Va3,  Va9,  Val0, Va34S-281, 
VaBMA, VcrBMB, VaA10,  Va13.1, VaBWB,  Va5T (13, 14); 
and  Va21  primer  5'-CAGCGCTGTCATCAACTGCA-3' (15). 
Reactions were heated to 94~  for 3 min, followed by four cycles 
of 97~  for 60 s, 52~  for 30 s, 72~  for 60 s, and 30 cycles of 
94~  for 45 s, 52~  for 30 s, and 72~  for 60 s. PCR products 
(7 gl) were electrophoresed on a 3% agarose gel (NuSieve; FMC 
Corp., Rockland, ME) and visualized  with ethidium bromide. Each 
Va PCR reaction yielding a band of the expected size was purified 
by filtration through a microconcentrator (Amicon, Beverly,  MA), 
and then directly sequenced  with a nested Ca sequencing primer 
(generously provided by K. Murphy, Washington University, St. 
Louis, MO) using a Taq DyeDeoxy terminator cycle sequencing 
kit (Applied Biosystems,  Foster City, CA) and a sequencer (model 
373A; Applied Biosystems). TCR-a chain rearrangements were 
determined to be in frame or out of frame by analysis  of the V-Ja 
junctional region sequences. All TCR-a V-J junctions differed at 
the nucleotide level. Va and Ja gene segments were assigned ac- 
cording to previous nomenclature (16, 17). The Va2 transgene was 
transcribed in all of the hybridomas. Expression of the V/31 trans- 
gene, which had cointegrated with the a  transgene, was verified 
for all hybridomas by activation by staphylococcal  enterotoxin A 
(Toxin Technology, Sarasota, FL) and/or RNA PCR of the ma- 
ture transcript of the/3 transgene. 
Results and Discussion 
To explore the effect of APL on unmanipulated primary 
T ceils, we generated a TCR-transgenic mouse based on the 
Hba(64-76)/I-Ek-specific Th2 clone 2.102  (7).  Upon char- 
acterization, these G2-Tg mice were phenotypically TCR-/3 
chain only-transgenic mice, because  the TCR-a chain was 
not the one used by the 2.102 T cells for Hba(64-76)  recog- 
nition. Thus, the T cells in the G2-Tg mice expressed a trans- 
genic/3 chain paired with endogenous o~ chains. Further char- 
acterization of the G2-Tg mice revealed that the transgenic 
chain alone,  in combination with endogenous a  chains, 
was sufficient  to confer antigen reactivity on unprimed T 
cells. Transgenic spleen cells responded weakly but specifically 
to either Hbb  a protein or Hba(64-76)  peptide (Fig. 1). A va- 
riety of APL of Hba(64-76) were also assayed, given the pos- 
sibility that TCR formed by the transgenic/3 chain and en- 
dogenous o~ chains would recognize the variants better than 
Hbd(64-76)  itself. Interestingly, G2-Tg spleen cells prolifer- 
ated strongly to Set69  (Fig.  1).  The vigorous proliferative 
response to Set69 indicated that the B chain alone had shaped 
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Figure 1.  Response  to peptide  antigens  by spleen  cells  from  G2-Tg  mice. 
Proliferation  by unprimed transgenic  spleen cells to the Ser69 (0), Hb  d- 
(64-76) (,), or Gln72 (A) peptides and by nontransgenic  cells to Set69 
(O). Spleen cells from littermates were assayed  in triplicate at 5 x  10  s 
cells/well with synthetic  peptides. Assays  were done in triplicate in 96- 
well flat-bottomed  plates in 0.2 ml RPMI-1640 supplemented  with 10% 
FCS, 2 mM glutamine,  50 gg/ml gentamycin,  and 2 x 10-s M 2-ME. 
The assay  was incubated  for 4 d and measured  as [3H]TdR (0.4 #Ci/well) 
incorporated over the last 20 h. 
the repertoire to contain a high frequency of Ser69-reactive 
T  cells.  Similar  antigen responsiveness  of unprimed cells 
has been reported in another TCR-/3 chain only-transgenic 
model (18). 
To characterize  the molecular basis for the Ser69 response, 
we generated a panel of Ser69-reactive T cell hybridomas from 
unprimed G2-Tg T cells stimulated in vitro with Ser69 and 
examined both specificity and TCR-c~ chain usage. These hy- 
bridomas separated  into two major groups based  on their 
specificity  for  Ser69  and  Hba(64-76).  One  group  (6/10) 
could be activated by Set69 only, not Hba(64-76),  and pre- 
dominantly expressed Vc~6-Jo~48 TCR-c~ rearrangements (Fig. 
2 A). The other group (4/10) consisted of T cells that were 
activated by both Ser69 and Hba(64-76),  and half of these 
expressed  Vc~4-Jo~33 TCR-c~  rearrangements (Fig.  2 B). 
Although the larger group of Ser69-reactive hybridomas 
was not activated  by Hba(64-76),  it was  still possible  that 
these T  cells engaged Hba(64-76),  but in a nonefficacious 
manner. Nonstimulatory peptides may act as specific antag- 
onists of the response  to the immunogenic ligand (4,  19). 
Thus, Hba(64-76)  was examined as a TCR antagonist of a 
representative  Ser69-reactive  hybridoma.  For BT,  a  Vo16- 
Jo~48-bearing  hybridoma, Hbd(64-76)  was not an agonist 
(Fig. 2 A), but did antagonize Ser69-mediated  activation in 
a specific and dose-dependent manner (Fig. 2 C), while a con- 
trol peptide did not. This finding demonstrated that although 
the BT TCR was activated only by Set69,  it still could spe- 
cifically interact with the Hbd(64-76)  peptide.  Thus, in the 
G2-Tg mouse, the roles of these two peptides had been reversed 
from the parent 2.102 clone (4), with Ser69 now being an 
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Figure 2.  Antigen  specificity  and TCR-ol  chain  usage of Ser69-reactive 
T cell hybridomas  derived  from Hbb  s/' G2-Tg mice. Responses  to Ser69 
(@) and Hbd(64-76) (I) for hybridomas  representative of the two an- 
tigen specificity  phenotypes,  along  with the types  and number  of in-frame, 
endogenous  V-Jc~ rearrangements  isolated  from  hybridomas  in each group. 
(/1) T cells  activated  by Ser69 only,  represented  by the BT hybfidoma  (Vc~6- 
Jo~48 TCR-c  0. (/3) T cells activated  by both Set69 and Hbd(64-76), rep- 
resented by the SCO hybridoma  (V~x4-Jc~33 TCR-c~). Results are mean 
values of CTLL-2 cell proliferation to 11.-2 released by the hybridomas, 
with SD <20%. (C) TCR antagonism  by Hbd(64-76) of BT T cell acti- 
vation. Inhibition  of Ser69-mediated  activation  of BT cells  was determined 
with no antagonist  (- - -) or in the presence of Flba(64-76) (.) or Gln72 
(A). Values are means _+ SD of triplicate cultures. Similar  results were 
obtained in three experiments. 
agonist and Hbd(64-76) an antagonist. This reversal provided 
us with an in vivo model to address the important question 
of how a TCR antagonist peptide expressed in the thymus 
would affect T  cell development. 
The important role of peptide-specific  interactions in T 
cell development was demonstrated in recent reports (20-22). 
Peptides  that  could  positively select  in  vitro  in  a  TCR- 
~x/B-transgenic system were TCR antagonists of the parent 
T cell clone (20). Peptides that could negatively select would 
stimulate the parent clone (20, 21). Extrapolating from these 
findings, we contend that each thymocyte must face a con- 
tinuum of different potential ligands, and the effects these 
various ligands have on developing T cells need to be clarified. 
To study the effect of an endogenous antagonist on T  cell 
development, we crossed the Ser69-reactive G2-Tg mice with 
CBA/J mice, which express the Hbb  a allele. We had shown 
previously that in Hbb  a mice, endogenous Hbba/I-E  k com- 
plexes are constitutively expressed on thymic cortical epithe- 
lial cells and medullary APC populations (23),  establishing 
that these complexes would be available to interact with de- 
veloping CD4 § T  cells. 
The presence  of the Hbb  a ligand altered the repertoire. 
In Hbb  a/~ mice,  vigorous T  cell  responses  to  Ser69  were 
observed,  as  had been found in Hbb  s/s background mice. 
In marked contrast, however,  cells from Hbb  d/s mice failed 
to  respond  to  Hbd(64-76)  (Fig.  3 A).  These  results  sug- 
gested that the endogenous Hbb  a ligand deleted at least all 
Hba(64-76)-reactive cells in the thymus, whereas Set69 only- 
reactive cells were allowed to develop. To gauge whether the 
endogenous Hbb  a ligand depleted the transgenic T cell rep- 
ertoire of any and all cells that interacted with it, Hba(64-76) 
was assayed as a TCR antagonist peptide. As shown in Fig. 
3 B, the primary Ser69 response by Hbb  a/~ G2-Tg cells was 
strongly and specifically inhibited by Hba(64-76) peptide, in- 
dicating that the Ser69-reactive T cells were capable of recog- 
nizing the ligand as an antagonist, and that a single peptide 
ligand can inhibit an oligoclonal T cell response. Furthermore, 
our results clearly show that TCR antagonism of unprimed 
peripheral  T  cells can occur. 
Comparison of the Set69  dose response  of transgenic T 
cells from Hbb  a/~ with that of Hbb  s/s mice revealed that a 
higher dose of Set69 was required to elicit a proliferative  re- 
sponse from Hbb  a/~ cells (Fig.  3 C). This shift in dose re- 
sponses were remarkably consistent, in that the data shown 
in Fig. 3 C were obtained from four individual mice for each 
group, each assayed  on different days. Thus, the observed differ- 
ences represented a significant shift in the primary response 
of bulk T cells to Ser69. The elimination of Ser69/Hbd(64 - 
76) dual-reactive cells only accounts for a minor proportion 
of this decreased response of the Hbb  d/~ G2-Tg cells, because 
in Hbb  r  mice these cells are a minority of Set69 responders 
(Fig. 2), and the weak Hba(64-76) response (Fig. 1) suggests 
a similarly limited contribution by dual-reactive  cells to the 
overall Set69 response. 
The large shift in  the Ser69  response  in Hbb  a/~ G2-Tg 
mice could be due in part to the endogenous Hbb  a in the 
thymus further restricting the Ser69-reactive repertoire to only 
low-avidity T cells. To test this possibility, the CD4 depen- 
dency of  the cells was evaluated. Antibody to CD4 more readily 
inhibited the  Ser69  response  of G2-Tg  spleen  cells  from 
Hbb  a/~ mice than that from Hbb  cs mice (Fig.  3 D), indi- 
cating that Hbb  d/s ceils were more dependent on CD4 core- 
ceptor for activation. This result suggested that the Ser69-re- 
active cells that emerged in Hbb  a/~ G2-Tg mice did recognize 
Ser69 with lower avidity. The Ser69-specific ceils that ma- 
tured were otherwise similar to ceils from Hbb cs mice (Fig. 
2 A), in terms of TCR-ol usage and precursor frequency (data 
not  shown)  and in  their recognition of Hbd(64-76)  as  a 
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Figure 3.  Effect  of the endoge- 
nous Hbb  d ligand on T cell devel- 
opment. (A) Activation  by Ser69, 
but not Hbd(64-76), of T  cells 
from Hbb  a/s G2-Tg mice. Prolif- 
erative responses to Ser69  (@) and 
Hbd(64-76) (i) were assayed as 
described in Fig. 1. Hbb  d/s G2-Tg 
mice were generated by mating 
CBA/J  mice with  an  Hbb  s/s, 
H-2k/Ltransgenic  mouse. (B) 
TCK antagonism by Hbd(64-76) 
of a bulk response  by T cells from 
Hbb  d/s G2-Tg mice. Ser69-acti- 
vated proliferation  in the presence 
of no antagonist (---), I-Ibd(64-76) 
(i), and with an I-ELbinding 
control, C/$ peptide (A). Nylon 
wool-purified T cells (2  x  10  s) 
from Hbb  a/s G2-Tg  mice were as- 
sayed as described  in Materials  and 
Methods. Proliferation  assays  were 
done in triplicate, and [3H]TdK 
incorporation was measured. A 
representative  of three separate  ex- 
periments is  shown. (C) Set69 
dose requirements of Hbb  d/s ver- 
sus Hbb  ~/s G2-Tg responders. Pro- 
liferation to Set69 by Hbb  s/~ (O) 
and Hbb  a/s (@) G2-Tg  spleen  cells. 
Values are means _+ SE of four 
separate assays  done on individual 
G2-Tg mice from the two Hbb 
backgrounds. (D) Greater CD4 
dependency  of Ser69-reactive  cells 
from Hbb  a/~ than  from Hbb  s/s 
G2-Tg mice. Hbb  '/s  (/eft) and 
Hbb  a/s (right) G2-Tg  spleen cells. 
Dilutions of anti-CD4 (GK1.5) 
antibody of 1:600 (11), 1:300 (V), 1:200 (@), 1:50 (A), or no anti-CD4 (O) were added with each of several submaximal doses of Set69, and prolifera- 
tion assays were done. Similar results were obtained in three experiments. 
TCR antagonist  (Figs.  2 B  and 3 B).  Overall, these results 
indicated that the endogenous APL selectively removed the 
high-avidity component of the T  cell response to Ser69, but 
allowed the remaining low-avidity Ser69-reactive cells to de- 
velop normally. 
Could the peripheral T  cell response to Ser69 be affected 
by antagonism by the endogenous Hbb  a ligand on APC? We 
have yet to  observe any  antagonism  by endogenous  Hbb  d 
complexes of Set69 responses of purified T cells, either from 
Hbb  s/~ or Hbb  a/s G2-Tg mice (data not shown). The number 
of complexes  may be  a  factor,  since  TCK  antagonism  is 
observable  under  carefully titrated  conditions  of subopti- 
mal agonist concentrations and antagonist excess (19). Also, 
differences between  the  endogenous  ligand  and  synthetic 
Hbd(64-76) peptide in either length, register, or conforma- 
tion within  the MHC  binding groove could translate into 
differences in antagonist ability. Jameson et al. (24) have re- 
cently shown that mature T  cells limit their response to the 
positive selecting ligand by decreasing the expression of CD8 
molecules. Thus, in the Hbb  d/s mice, perhaps surface levels 
of CD4 are decreased as part of the regulation in preventing 
the endogenous Hb  d (64-76) from antagonizing  the Ser69 
response. The CD4 level may not need drastic downregula- 
tion to see an effect, given that expression of TCR and other 
coreceptors also may determine whether antagonism occurs. 
We would argue that,  in the periphery, most endogenous 
peptides can act as antagonists  only under unique circum- 
stances such as increased expression of the endogenous pep- 
tide or the upregulation  of important  molecules for T  cell 
activation. 
The multiple interactions between Hbd(64-76) and differ- 
ent TCR in this system demonstrate that the capacity to finely 
discriminate between very similar ligands can govern the fate 
of a T  cell.  We propose the following model,  depicted in 
Fig. 4,  to explain our data.  In the thymus,  for each TCK, 
a corresponding set of functionally similar "lookalike" ligands 
defines a narrow avidity window for positive and negative 
selection (25, 26). Of note, the Hbb d/s thymus differs from 
the Hbb s/~ thymus because the added endogenous Hbb a de- 
terminant changes the avidity window for selection. In the 
Hbb ~/~ thymus,  the  two  specificity types of Ser69-reactive 
cells (Fig.  2) are positively selected on their respective sets 
of ligands,  and proceed to mature. TCR affinity, TCR and 
coreceptor levels, and determinant density all contribute to 
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for the effect of the endogenous 
APL, Hbd(64-76), on the devel- 
opment of the Set69 response. In 
G2-Tg mice, two  Ser69-reactive 
populations  ofT cells  occur: Ser69 
only and Ser69/Hbd(64-76) dual 
reactive. In the thymus of Hbb  s/s 
mice, these two populations en- 
counter many potential ligands 
from  the  endogenous peptide: 
MHC pool, some of which are 
positively  selecting  (P). The posi- 
tively selected  T cells mature and 
exit the thymus.  In the periphery, 
the Ser69 only-reactive  T cells  can 
be antagonized  by the Hbd(64-76) 
synthetic  peptide. In the thymus 
of Hba/s-transgenic  mice, both T 
cell populations encounter nu- 
merous ligands,  including  the en- 
dogenous Hbb  d ligand (Hb). The 
dual-reactive  cells and high-avidity 
Ser69-reactive cells engage the 
I-Ibb  d ligand sufficiently to  in- 
duce  deletion.  Low-avidity  Ser69- 
reactive T cells, which are more 
antigen and CD4 dependent,  de- 
velop and exit into the periphery. 
Like their  Hbb  s/s  background 
counterparts, these low-avidity 
Ser69-reactive peripheral T cells 
from Hbb  d/s mice can be antago- 
nized by  the  exogenous Hb  d- 
(64-76) synthetic peptide. 
avidity and influence thymic selection (21, 27-30). Thus, both 
the Ser69/Hbd(64-76)  dual-reactive cells and higher avidity 
Ser69 only-reactive ceils engage the endogenous Hba(64-76) 
ligand enough that they are negatively selected. Other Ser69- 
reactive ceils do not interact strongly with endogenous Hbb  a 
and are still positively selected because their avidity window 
has not changed. 
After exiting into the periphery, mature T  cells appear to 
have higher thresholds of activation than thymocytes (31). 
Thus, ligands that are weak agonists for peripheral T  cells 
are very effective at inducing thymic deletion (31).  Similarly, 
since Hba(64-76) interacted with peripheral T  cells as a TCtL 
antagonist in Hbb  a/s G2-Tg mice (Fig. 3 B), these cells prob- 
ably were  more  sensitive  to  the endogenous  Hbb  d ligand 
during thymic development. However, this interaction was 
too weak (in affinity or avidity) or nonefficacious to induce 
thymocyte deletion (26).  In fetal thymic organ culture studies, 
it has been demonstrated that lower avidity TCtL interactions 
allow positive selection, and higher avidity ones result in nega- 
tive selection (20,  21).  In the G2-Tg mice, the endogenous 
Hbb  d ligand may act as a positively selecting peptide look- 
alike for Ser69-specific cells. Other endogenous peptide look- 
alikes must serve to positively select as well, since Ser69-specific 
cells  emerge  in  Hbbs/s-transgenic  mice,  which  lack  Hbb  a 
ligand. Such endogenous ligands would probably function 
as TCR  antagonists;  however,  we contend  that  TCR  an- 
tagonism is not directly equated with the ability to positively 
select. TCR antagonist activity is principally an in vitro prop- 
erty displayed by a class of ligands. In the continuum of in- 
teractions between a TCR and different APL, positive selection 
and antagonist peptides  represent  separate but  overlapping 
portions  of the spectrum  (1). 
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